Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Depreciation and Depletion (2017 - 2025)

Selectis Health's Depreciation and Depletion history spans 10 years, with the latest figure at $374118.0 for Q3 2024.

  • For Q3 2024, Depreciation and Depletion rose 4.54% year-over-year to $374118.0; the TTM value through Sep 2024 reached $1.6 million, down 2.48%, while the annual FY2023 figure was $1.7 million, 7.06% down from the prior year.
  • Depreciation and Depletion for Q3 2024 was $374118.0 at Selectis Health, down from $409530.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $1.7 million in Q1 2021 and bottomed at -$447070.0 in Q3 2021.
  • The 5-year median for Depreciation and Depletion is $427176.5 (2023), against an average of $441425.8.
  • The largest YoY upside for Depreciation and Depletion was 366.0% in 2021 against a maximum downside of 215.29% in 2021.
  • A 5-year view of Depreciation and Depletion shows it stood at $405401.0 in 2020, then rose by 10.28% to $447070.0 in 2021, then decreased by 0.64% to $444195.0 in 2022, then fell by 3.03% to $430754.0 in 2023, then decreased by 13.15% to $374118.0 in 2024.
  • Per Business Quant, the three most recent readings for GBCS's Depreciation and Depletion are $374118.0 (Q3 2024), $409530.0 (Q2 2024), and $423599.0 (Q1 2024).